| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| ChiCTR2600129504 |
|
|
Therapy Study |
|
2026-08-05 | 11 | Patient list |
| 0 |
Beijing United Family Hospital |
|
Therapy Study |
Post-market |
2026-08-05 | 10 | Patient list |
| 0 |
Beijing United Family Hospital |
|
Therapy Study |
Post-market |
2026-08-05 | 11 | Patient list |
| 0 |
Beijing United Family Hospital |
|
Therapy Study |
Post-market |
2026-08-05 | 12 | Patient list |
| ITMCTR2026001779 |
|
|
|
|
2026-08-03 | 34 | Patient list |
| 2023-SR-926 |
|
|
|
|
2026-07-31 | 62 | Patient list |
| 2026-K001-01 |
Clinical study of Anjiang granule in the treatment of grade 1 hypertension Xiamen Hospital of traditional Chinese Medicine |
|
Therapy Study |
Premarket |
2026-07-28 | 84 | Patient list |
| MR-51-25-066602 |
|
|
Therapy Study |
Post-market |
2026-07-28 | 98 | Patient list |
| test |
|
|
|
|
2026-07-28 | 73 | Patient list |
| MR-31-25-072121 |
|
|
Therapy Study |
Post-market |
2026-07-28 | 83 | Patient list |